rs3752648
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002907.4(RECQL):c.950-33A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.477 in 1,544,720 control chromosomes in the GnomAD database, including 177,026 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002907.4 intron
Scores
Clinical Significance
Conservation
Publications
- RECON progeroid syndromeInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL | NM_002907.4 | c.950-33A>G | intron_variant | Intron 8 of 14 | ENST00000444129.7 | NP_002898.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.492 AC: 74602AN: 151742Hom.: 18424 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.480 AC: 115804AN: 241328 AF XY: 0.477 show subpopulations
GnomAD4 exome AF: 0.476 AC: 662925AN: 1392860Hom.: 158575 Cov.: 23 AF XY: 0.475 AC XY: 330385AN XY: 696156 show subpopulations
GnomAD4 genome AF: 0.492 AC: 74672AN: 151860Hom.: 18451 Cov.: 33 AF XY: 0.491 AC XY: 36474AN XY: 74212 show subpopulations
ClinVar
Submissions by phenotype
not provided Benign:2
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at